CA-TRM-LABS
13.6.2022 18:34:07 CEST | Business Wire | Press release
Today, TRM Labs, the blockchain intelligence company, announced the acquisition of CSITech, a global leader in crypto and blockchain investigative training. CSITech adds its nearly two decades of investigative training experience to TRM’s suite of compliance tools and service offerings for crypto business, government and law enforcement agency, and financial institution clientele.
CSITech, a UK-based firm, delivers in-person and online training on blockchain and cryptocurrency investigations. CSITech is widely recognized as the leading crypto investigations training firm and has trained international law enforcement bodies at all levels on investigative techniques and best practices for investigating cryptocurrency-related crimes.
“TRM is on a mission to bring trust and safety to the crypto economy. Providing first-rate tools and training to law enforcement and compliance professionals that help safeguard this ecosystem is a core component,” said Esteban Castaño, co-founder and CEO of TRM Labs. “We’re excited about the expanded training capabilities Nick and his team of experts will allow us to offer to our global base of customers.”
CSITech’s expertise will augment and expand TRM’s existing portfolio of training services, which includes TRM Academy – an extensive library of self-serve digital courses available to all TRM customers as a complimentary resource – and several multi-day certification courses designed to advance the skills of professionals ranging compliance practitioners who are new to crypto to experienced crypto investigators.
“We’re committed to delivering the best training and certifications to our students, clients and partners in pursuit of our tireless mission to see the crypto space become a safer and more trustworthy environment for all,” said Nick Furneaux, Managing Director at CSITech.
“The pro level courses we are delivering are for those with a high existing knowledge base, who have taken a number of existing courses available and are looking to acquire the techniques and skills to take their capabilities, services offerings and careers to the next level.”
Mr. Furneaux is an internationally renowned expert of blockchain forensics and author of Investigating Cryptocurrencies: Understanding, Extracting, and Analyzing Blockchain Evidence (2018) . In 18 years of operation, CSITech established itself as the preeminent crypto investigations training provider with top law enforcement agents among its alumni. Former pupils are currently leading some of the most well known cryptocurrency investigations in the sector, including cases involving hacks against exchanges, organized crime groups and sanctions evasion.
“Since 2019, TRM Labs has constantly innovated to build a blockchain investigations tool for today’s crypto ecosystem. We at CSITech are thrilled to join TRM on its mission to build a safer financial system for billions of people and expand our capability to train the next generation of leading cryptocurrency investigators,” said Furneaux. He and other CSITech personnel join TRM’s Training and Certifications team, operating in close collaboration with TRM’s Global Investigations team led by former IRS-Criminal Investigations (IRS-CI) Special Agent Chris Janczewski, who joined TRM in March 2022.
“The cryptocurrency space is evolving at tremendous pace and requires investigators and industry leaders to educate and prepare to match the industry’s scale,” said Chris Janczewski, Head of Global Investigations for TRM. “My team and I work closely with TRM’s Training and Certifications program to ensure that the course material continues to reflect the reality of the job on the ground.”
TRM’s certifications portfolio includes a range of multi-day course offerings that can be delivered virtually or in-person: TRM Crypto Fundamentals Certification (TRM-CFC), TRM Certified Crypto Compliance Specialist (TRM-CCS), TRM Certified Investigator (TRM-CI) and TRM Advanced Crypto Investigator (TRM-ACI). For more information and to enquire about booking group or individual courses, visit the TRM website here .
About TRM Labs
TRM provides blockchain intelligence to help financial institutions, cryptocurrency businesses and public agencies detect, investigate and manage crypto-related fraud and financial crime. TRM's risk management platform includes solutions for cryptocurrency anti-money laundering (AML), transaction monitoring and wallet screening, entity risk scoring including Know-Your-VASP, and transaction tracing for investigations. These tools enable a rapidly growing cohort of organizations around the world to safely embrace cryptocurrency-related transactions, products, and partnerships. TRM is based in San Francisco, CA and is hiring across engineering, product, sales, and data science. To learn more, visit www.trmlabs.com .
View source version on businesswire.com: https://www.businesswire.com/news/home/20220613005731/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
IQM Appoints Craig Ciesla, Former Illumina VP, as CTO; Inés de Vega Becomes Chief Scientist19.6.2026 09:00:00 CEST | Press release
Ciesla is a seasoned deep tech executive with more than 25 years of experience delivering products across industries — from startups to Fortune 500 companies. De Vega brings more than 20 years of experience advancing quantum technologies from fundamental research to intellectual property and industrial applications. IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointments of Dr. Craig Ciesla as Chief Technology Officer (CTO) and Dr. Inés de Vega as Chief Scientist, as she transitions from her role as Vice President of Quantum Solutions, deepening IQM´s leadership as the company prepares for its planned Nasdaq listing through a merger with Real Asset Acquisition Corp. (Nasdaq: RAAQ). This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260619693929/en/ From left to right: Dr. Inés de Vega, Chief Scientist, and Dr. Craig Ciesla, Chief Technology Officer. Ciesla, an experienced d
Teijin Receives Approval for Additional Indications of XEOMIN® for Cervical Dystonia and Blepharospasm in Japan19.6.2026 09:00:00 CEST | Press release
Teijin Pharma Limited, the core company of the Teijin Group’s healthcare business, and Merz Therapeutics GmbH, a leading player in neurology-focused specialty pharma, jointly announced today that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved the additional indications for XEOMIN® (incobotulinumtoxinA) for the treatment of cervical dystonia and blepharospasm. This approval represents the fourth and fifth indications for XEOMIN® authorized in Japan, alongside its existing approvals for the treatment of upper limb spasticity, lower limb spasticity and chronic sialorrhea. Cervical dystonia is a focal dystonia characterized by involuntary contractions of the neck muscles, resulting in abnormal or repetitive movements and postures.1 Blepharospasm is also a focal dystonia, characterized by excessive involuntary contractions of the muscles surrounding the eye.2 Both conditions significantly impact patients’ quality of life. The approval by MHLW is based on Phase III clinic
Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)19.6.2026 08:00:00 CEST | Press release
Incyte Biosciences Japan G.K. today announced that Japan’s Ministry of Health, Labour and Welfare (MHLW) has approved Minjuvi® (tafasitamab) in combination with lenalidomide for the treatment of adults with relapsed or refractory diffuse large B-cell lymphoma (DLBCL). “This approval provides a new option for patients in Japan living with relapsed or refractory DLBCL, an aggressive disease with historically limited treatment options,” said Yasuyuki Ishida, General Manager, Incyte Biosciences Japan. “We are committed to helping address critical unmet needs for patients and their families affected by this challenging cancer.” DLBCL is the most common subtype of non-Hodgkin lymphoma and is an aggressive malignancy of B lymphocytes. While many patients respond to initial therapy, outcomes remain poor for those with relapsed or refractory disease, particularly for patients who are not eligible for autologous stem cell transplant.1 The approval is based on results from the MOR208C203 Trial: L
Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training18.6.2026 19:07:00 CEST | Press release
New multi-sensor system captures heart rate, movement quality, stability and muscle load to provide a more complete view of performance under fatigue Amazfit, a leading global smart wearable brand owned by Zepp Health (NYSE: ZEPP), today announced Helio Strap Pro, a body-worn training system designed to help HYROX and hybrid athletes better understand how their bodies perform under load. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260618031434/en/ Amazfit Introduces Helio Strap Pro, Bringing Body-Worn Movement Intelligence to HYROX and Hybrid Training Building on the screen-free Helio Strap, Helio Strap Pro adds a dedicated waist-mounted motion sensor that captures core-body movement and stability during training. Combined with upper-arm heart-rate sensing and compatible Amazfit smartwatches, the system provides a more complete picture of cardio effort, movement quality and muscle load than wrist-based tracking alone. Hel
HyperLight Announces $80 Million Series C to Accelerate TFLN Deployment for AI Infrastructure18.6.2026 17:30:00 CEST | Press release
HyperLight Corporation (“HyperLight”), a leader in thin-film lithium niobate (TFLN) photonics, today announced the closing of an $80 million Series C financing round led by MediaTek. The round includes participation from UMC Capital, Jabil, Foxconn, EDBI (arm of SG Growth Capital, the investment platform of the Singapore Economic Development Board and Enterprise Singapore), CDIB-TEN Capital, and Qatar Investment Authority (QIA), as well as strategic investors from leading silicon IC and networking companies. Existing investors Summit Partners, The Engine, Foothill Ventures, and Xora Innovation continue to actively support the company’s growth. The financing brings together companies across the AI infrastructure value chain — including silicon ICs, foundry manufacturing, electronics manufacturing services, networking, and global infrastructure investment — reflecting broad ecosystem support for scaling TFLN photonics into production. “This financing is about more than capital — it is ab
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
